Alzheimer’s Disease Diagnostics Must Be Globally Accessible

Dementia and Alzheimer’s disease (AD) are global health crises, with most affected individuals living in low- or middle-income countries. While research into diagnostics and therapeutics remains focused exclusively on high-income populations, recent technological breakthroughs suggest that low-cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Clute-Reinig, Nicholas, Jayadev, Suman, Rhoads, Kristoffer, Le Ny, Anne-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764591/
https://www.ncbi.nlm.nih.gov/pubmed/34690142
http://dx.doi.org/10.3233/JAD-210663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764591/
https://www.ncbi.nlm.nih.gov/pubmed/34690142
http://dx.doi.org/10.3233/JAD-210663

Ejemplares similares